Mark Asset Management LP Moderna, Inc. Call Options Transaction History

Mark Asset Management LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $2.41 Million - $3.17 Million	25,000 New	25,000 $2.58 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $2.37 Million - $4.2 Million	20,000 New	20,000 $3.59 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $1.26 Million - $2.35 Million	-10,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $2.26 Million - $3.69 Million	10,000 New	10,000 $2.54 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mark Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Mark Asset Management LP with notifications on news.